TLSI Q2 2023 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M+60.3% YoY

Gross Profit

$4M83.3% margin

Operating Income

-$11M-247.9% margin

Net Income

-$14M-303.0% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

+54.6%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$68,000

Balance Sheet

Total Assets

$17M

Total Liabilities

$34M

Stockholders' Equity

-$17M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+60.3%
Gross Profit	$4M	$3M	+52.7%
Operating Income	-$11M	-$9M	-32.0%
Net Income	-$14M	-$9M	-61.0%